HOME INVESTOR DAY PRESENTATIONS MYRIAD MILESTONES Health. Illuminated. Advancing Our Purpose Meet Our Catalysts Myriad Genetics has a new CEO and proven leaders who are advancing our mission and our company. The below executives presented initiatives to position Myriad for transformation and growth on Investor Day. Investor Day Presenters Media Contact Jared Maxwell (801) 505-5027 jmaxwell@myriad.com Investor Relations Contact Nathan Smith (801) 505-5067 nathan.smith@myriad.com Corporate Headquarters 800 4-MYRIAD Myriad Genetics, Inc. 320 Wakara Way Salt Lake City, UT 84108 Investor Relations Terms of Use Privacy Policy Language Assistance © 2021 Myriad Genetics, Inc.

Patients Providers Products About Contact INVESTORS > NEWS RELEASES News Releases Categories: All Categories Corporate Products Pipeline Financial Nov 23, 2021 The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults Products Nov 22, 2021 Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment Pipeline Nov 02, 2021 Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans Financial Oct 27, 2021 Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021 Financial Oct 18, 2021 Myriad Genetics Names Pamela Wong as Chief Legal Officer Corporate Oct 11, 2021 Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey Products Sep 13, 2021 Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing Business to LabCorp Corporate Sep 08, 2021 Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey Products Aug 03, 2021 Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans Financial Aug 02, 2021 Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries Pipeline Jul 28, 2021 Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021 Financial Jul 28, 2021 New research reveals most Americans can’t identify the symptoms of depression Products Jul 21, 2021 Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities Corporate Jul 01, 2021 Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions Corporate Jun 16, 2021 Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics Corporate Next page Payers Overview Investors Events + Presentations News Press Releases Myriad Genetics Blog Careers Joining the Team Terms of UseMyriad Genetics, Inc. Privacy PolicyLanguage Assistance Cookie Preferences © 2021 Myriad Genetics, Inc. reCAPTCHA helps prevent automated form spam. The submit button will be disabled until you complete the CAPTCHA.